Kisunla BRAND Launch

100 key claim documents (literally).

Probably as many MRO meetings.

Email newsletter, websites, banners, social posts, brochures.

Branded and unbranded, DTC and HCP alike.

I’ve done them all.

Since April 2022, I’ve been working on launching Lilly’s groundbreaking new Alzheimer’s medication, Kisunla (donanemab).

When launch day came in early July 2024, we were ready.

As a result of our work, my team won “best launch of 2024” at AREA23’s Hero Awards.